Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of novel BTK PROTACs with improved metabolic stability via linker rigidification strategy
Song Chen, Zhendong Chen, Lixue Lu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 255, pp. 115403-115403
Closed Access | Times Cited: 18

Showing 18 citing articles:

Characteristic roadmap of linker governs the rational design of PROTACs
Yawen Dong, Tingting Ma, Ting Xu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 10, pp. 4266-4295
Open Access | Times Cited: 22
Application and challenges of nitrogen heterocycles in PROTAC linker
Yang Li, Junfeng Qu, Lizhi Jiang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 273, pp. 116520-116520
Closed Access | Times Cited: 13
Modulating the phosphorylation status of target proteins through bifunctional molecules
Qindi He, Zhijie Wang, Rongrong Wang, et al.
Drug Discovery Today (2025), pp. 104307-104307
Closed Access | Times Cited: 1
Cutting-edge biotherapeutics and advanced delivery strategies for the treatment of metabolic dysfunction-associated steatotic liver disease spectrum
Juhyeong Hong, Yong‐Hee Kim
Journal of Controlled Release (2025) Vol. 380, pp. 433-456
Closed Access | Times Cited: 1
Novel Amphiphilic PROTAC with Enhanced Pharmacokinetic Properties for ALK Protein Degradation
Shirui Wang, Zhanzhan Feng, Can Qu, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 12, pp. 9842-9856
Closed Access | Times Cited: 7
Combinatorial Ubiquitination REal-time PROteolysis (CURE-PROs): A Modular Platform for Generating Reversible, Self-Assembling Bifunctional Targeted Degraders
Sarah F. Giardina, Elena Valdambrini, Pradeep K. Singh, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 7, pp. 5473-5501
Closed Access | Times Cited: 4
In silico modeling of targeted protein degradation
Wenxing Lv, Xiaojuan Jia, Bowen Tang, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117432-117432
Open Access
Design, Synthesis, and Biological Evaluation of Novel BTK-targeting Proteolysis Targeting Chimeras (PROTACs) with Enhanced Pharmacokinetic Properties
Ying‐Hung Lin, Jing Liu, Xiaohe Tian, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117420-117420
Closed Access
Discovery of Novel Rigid STING PROTAC Degraders as Potential Therapeutics for Acute Kidney Injury
Rui Ma, Renquan Fu, Yifan Wang, et al.
European Journal of Medicinal Chemistry (2025), pp. 117539-117539
Closed Access
Protein kinases: The key contributors in pathogenesis and treatment of nonalcoholic fatty liver disease-derived hepatocellular carcinoma
Rong Liu, Mingping Qian, Ying‐Yu Cui
Metabolism (2023) Vol. 147, pp. 155665-155665
Closed Access | Times Cited: 9
Exploration of Hydrazide-Based HDAC8 PROTACs for the Treatment of Hematological Malignancies and Solid Tumors
Chunlong Zhao, Jianqiu Zhang, Hangyu Zhou, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 16, pp. 14016-14039
Open Access | Times Cited: 3
Effect of mitochondrial translocator protein TSPO on LPS-induced cardiac dysfunction
Xingyue Li, Xiao Chen, Feng-Yuan Yang, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 2
Selective and Potent PROTAC Degraders of c-Src Kinase
Wuxiang Mao, Nathalie M. Vandecan, C. Raymond Bingham, et al.
ACS Chemical Biology (2023) Vol. 19, Iss. 1, pp. 110-116
Closed Access | Times Cited: 6
Bruton Tyrosine Kinase Degraders in B-Cell Malignancies
T. N. Huynh, Sonia Rodriguez‐Rodriguez, Alexey V. Danilov
Molecular Cancer Therapeutics (2024) Vol. 23, Iss. 5, pp. 619-626
Closed Access | Times Cited: 1
Stereochemical inversion at a 1,4-cyclohexyl PROTAC linker fine-tunes conformation and binding affinity
Martina Pierri, Xingui Liu, Alena Kroupova, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 110, pp. 129861-129861
Open Access | Times Cited: 1
PROTACs: Principles and Mechanisms
Ranbir Singh Saluja, Madhura P. Vaidya, Prashant S. Kharkar
(2024), pp. 21-38
Closed Access
Discovery of orally bioavailable ALK PROTACs based Ceritinib against ALK positive cancers
Haoxuan Zhou, Mingxing Hu, Hui Jie, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116827-116827
Closed Access
Characterization of preclinical radio ADME properties of ARV-471 for predicting human PK using PBPK modeling
Yifei He, Chenggu Zhu, Lei Peng, et al.
Journal of Pharmaceutical Analysis (2024), pp. 101175-101175
Open Access
Page 1

Scroll to top